Terns Pharmaceuticals Inc (TERN)
5.04
-0.06
(-1.18%)
USD |
NASDAQ |
Apr 30, 16:00
5.04
0.00 (0.00%)
After-Hours: 17:45
Terns Pharmaceuticals Cash from Investing (Quarterly): 47.23M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 47.23M |
| September 30, 2023 | -22.31M |
| June 30, 2023 | -90.84M |
| March 31, 2023 | 27.93M |
| December 31, 2022 | -14.55M |
| September 30, 2022 | -1.24M |
| June 30, 2022 | -15.97M |
| March 31, 2022 | 9.488M |
| Date | Value |
|---|---|
| December 31, 2021 | -6.421M |
| September 30, 2021 | 4.443M |
| June 30, 2021 | -20.90M |
| March 31, 2021 | -96.82M |
| December 31, 2020 | -0.047M |
| September 30, 2020 | -0.005M |
| June 30, 2020 | -0.102M |
| March 31, 2020 | 6.847M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-96.82M
Minimum
Mar 2021
47.23M
Maximum
Dec 2023
-10.83M
Average
-0.671M
Median
Cash from Investing (Quarterly) Benchmarks
| Viking Therapeutics Inc | -459.79M |
| Eli Lilly and Co | -2.924B |
| Pfizer Inc | -11.00B |
| Amgen Inc | -27.09B |
| Madrigal Pharmaceuticals Inc | -362.12M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -19.32M |
| Cash from Financing (Quarterly) | 13.86M |
| Free Cash Flow | -67.44M |
| Free Cash Flow Per Share (Quarterly) | -0.2676 |
| Free Cash Flow Yield | -18.78% |